TCM
EW icon

Teza Capital Management’s Edwards Lifesciences EW Stock Holding History

Teza Capital Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,753
Closed -$235K – 92
2025
Q4 		$235K Sell
2,753
-110
-4% -$9.03K 0.76% 57
2025
Q3 		$223K Sell
2,863
-14,078
-83% -$1.1M 1.2% 42
2025
Q2 		$1.32M Sell
16,941
-2,643
-13% -$197K 0.99% 7
2025
Q1 		$1.42M Sell
19,584
-71,252
-78% -$5.1M 0.65% 21
2024
Q4 		$6.72M Buy
90,836
+10,997
+14% +$770K 1.02% 11
2024
Q3 		$5.27M Buy
+79,839
New +$5.8M 0.58% 33
2024
Q2 		– Sell
-14,596
Closed -$1.39M – 636
2024
Q1 		$1.39M Sell
14,596
-4,257
-23% -$358K 0.19% 153
2023
Q4 		$1.44M Sell
18,853
-38,098
-67% -$2.65M 0.24% 134
2023
Q3 		$3.95M Buy
56,951
+53,999
+1,829% +$4.34M 0.64% 28
2023
Q2 		$278K Sell
2,952
-10,686
-78% -$929K 0.05% 426
2023
Q1 		$1.13M Sell
13,638
-1,095
-7% -$86.1K 0.24% 129
2022
Q4 		$1.1M Buy
+14,733
New +$1.14M 0.21% 151
2022
Q2 		– Sell
-4,800
Closed -$565K – 453
2022
Q1 		$565K Sell
4,800
-485
-9% -$54.4K 0.21% 146
2021
Q4 		$685K Sell
5,285
-1,526
-22% -$178K 0.18% 157
2021
Q3 		$771K Sell
6,811
-828
-11% -$94.5K 0.37% 79
2021
Q2 		$791K Sell
7,639
-1,299
-15% -$122K 0.13% 217
2021
Q1 		$748K Buy
+8,938
New +$756K 0.15% 199
2020
Q1 		– Sell
-8,976
Closed -$698K – 257
2019
Q4 		$698K Buy
+8,976
New +$701K 0.19% 170
2019
Q3 		– Sell
-5,919
Closed -$364K – 535
2019
Q2 		$364K Buy
5,919
+1,983
+50% +$120K 0.21% 172
2019
Q1 		$251K Buy
+3,936
New +$225K 0.13% 237
2018
Q3 		– Sell
-27,342
Closed -$1.33M – 428
2018
Q2 		$1.33M Buy
+27,342
New +$1.28M 0.2% 161
2017
Q2 		– Sell
-15,423
Closed -$484K – 140
2017
Q1 		$484K Buy
+15,423
New +$483K 0.14% 247

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Teza Capital Management's EW Position: Q1 2026 in Review

Teza Capital Management sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 2,753 shares — an estimated $235K sold.

Teza Capital Management first reported a position in EW in Q1 2017 and held it in 22 quarters. The position peaked at $6.72M in Q4 2024. 1,292 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Teza Capital Management reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • Teza Capital Management sold 2,753 Edwards Lifesciences shares in Q1 2026, an estimated $235K.
  • Teza Capital Management first reported a position in Edwards Lifesciences in Q1 2017 and held it in 22 quarters.
  • Teza Capital Management's Edwards Lifesciences position peaked at $6.72M in Q4 2024.
  • 1,292 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Teza Capital Management's 13F filing for Q1 2026, filed 15 May 2026.